Why Bubs, Dicker Data, Navigator Global, & Saracen shares stormed higher today

The Bubs Australia Ltd (ASX:BUB) share price and the Dicker Data Ltd (ASX:DDR) share price are two of four storming higher on Friday…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade the S&P/ASX 200 index is on course to finish the week on a reasonably subdued note. At the time of writing the benchmark index is down around 0.1% to 6,377.9 points.

Four shares that have not let that hold them back today are listed below. Here's why they have stormed higher on Friday:

The Bubs Australia Ltd (ASX: BUB) share price has jumped a further 8% to $1.05. The goat milk infant formula company's shares raced higher after it announced the completion of its Australia Deloraine Dairy acquisition. Management believes this acquisition leaves Bubs well placed to advance its vision of being a leading player in the infant milk formula and infant nutritionals markets both at home and in the massive China market.

The Dicker Data Ltd (ASX: DDR) share price has raced 3.5% higher to $4.21 after the leading wholesale distributor of computer software and hardware revealed that one of its directors has been buying shares on-market. According to a change of director's interest notice, Dicker Data's COO, Vladimir Mitnovetski, picked up around $225,000 worth of shares through an on-market trade earlier this week.

The Navigator Global Investments Ltd (ASX: NGI) share price has zoomed 9.5% higher to $3.83 despite there being no news out of the investment company. However, with its shares trading significantly lower than their 52-week high of $6.24, some investors may believe they are currently in the bargain bin and have been snapping them up today.

The Saracen Mineral Holdings Limited (ASX: SAR) share price has risen 5.5% to $2.71. A rise in the gold price and increased demand for safe haven assets appears to have been the reason for this strong share price gain. A number of Australian gold miners are ending the week strongly, leading to the S&P/ASX All Ords Gold index climbing 2.1% this afternoon.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »